Subscribe

First Patients in Ovarian Cancer Trial

First patients dosed in phase 2 platform clinical trial testing novel immunotherapy combinations in highly malignant ovarian...

PD1/PDL1 Immuno-Oncology Landscape Trends

CRI’s latest analysis of the PD1/PDL1 immuno-oncology landscape confirms trends in trial design and patient enrollment, points...

mRNA Vaccine Creators to Receive 2021 William B. Coley Award

Four Key Scientists Behind the Vaccines to Share Virtual Stage at November 10 Event; Katalin Karikó, Ugur...

First patients with metastatic pancreatic cancer begin treatment in new clinical trial from CRI and PICI

The first patients have enrolled in a platform clinical trial, called REVOLUTION, testing combination immunotherapy in patients...

CRI to Host Second Virtual Immunotherapy Patient Summit

CRI's free and live online event for patients and caregivers covering cancer immunotherapy, clinical trials, and cancer...

Ana Patricia Gámez Joins CRI in the Movement for Racial Health Equity

CRI’s free virtual event to connect U.S. Hispanic cancer patients and caregivers with leading cancer experts to...

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.